Ceribell, Inc. CBLL recently announced that it has received FDA clearance for the Clarity algorithm for use in pediatric patients. This breakthrough expands the utility of Ceribell’s rapid ...
Updated NCCN pediatric STS guidelines emphasize risk stratification, imaging, multimodal therapy, and clinical trial enrollment to improve outcomes. The National Comprehensive Cancer Network (NCCN) ...
Powered by Clarity, the Ceribell System will enable rapid, bedside detection, diagnosis and treatment of non-convulsive seizures in children experiencing neurological emergencies SUNNYVALE, Calif., ...
News-Medical.Net on MSN
NCCN publishes new guidelines for management of pediatric soft tissue sarcomas
The National Comprehensive Cancer Network ® (NCCN ® ) today published new NCCN Clinical Practice Guidelines in Oncology (NCCN ...
The American Society of Hematology (ASH) has published new clinical practice guidelines for the management of acute lymphocytic leukemia (ALL) in adolescents and young adults (AYAs). 1 ...
This past year, researchers at Children's Hospital of Eastern Ontario announced the development of a new artificial intelligence-enabled search algorithm that can help identify patients who might have ...
The American Society of Hematology (ASH) released guidelines on frontline management of acute lymphoblastic leukemia (ALL) in adolescents and young adults (AYAs), as well as the management of relapsed ...
SUNNYVALE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results